National NSF I-Corps alum startup raises 26M

National NSF I-Corps program alumni startup Amber Bio raised a 26M seed round led by Playground Global, Eli Lilly, Andreessen Horowitz, and Hummingbird Ventures.

Current DNA editing treats only one mutation at a time, causes permanent genetic modifications and comes with potentially irreversible safety risks. That’s where San Francisco-based Amber Bio comes in. It uses Crispr gene editing tools to target RNA, rather than DNA, which has the potential to correct a broader variety of genetic disorders while reducing safety risks.

Amber cofounder Basem Al-Shayeb says that the current approach many biotech and pharmaceutical companies are taking to gene editing is like having a word processor “Individually searching for correcting different typos across hundreds of different files.”

Learn more about Amber Bio in the entire article here:

https://www.forbes.com/sites/indiarice/2023/08/03/this-startup-just-raised-26-million-to-develop-safer-gene-editing-tools/?sh=113d97f4382b